Rhenman & Partners Asset Management’s Teladoc Health TDOC Stock Holding History

Rhenman & Partners Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-130,000	Closed	-$3.07M	–	95
2022 Q4	$3.07M	Hold	130,000	–	–	0.32%	72
2022 Q3	$3.85M	Buy	130,000 +45,000	+53%	+$1.58M	0.4%	68
2022 Q2	$2.82M	Sell	85,000 -7,000	-8%	-$297K	0.32%	68
2022 Q1	$6.64M	Sell	92,000 -33,000	-26%	-$2.38M	0.65%	53
2021 Q4	$11.8M	Sell	125,000 -25,000	-17%	-$2.99M	0.78%	46
2021 Q3	$19M	Sell	150,000 -60,000	-29%	-$8.74M	1.34%	27
2021 Q2	$34.9M	Buy	210,000 +20,000	+11%	+$3.24M	2.37%	7
2021 Q1	$34.5M	Buy	190,000 +75,000	+65%	+$17.4M	2.41%	8
2020 Q4	$23M	Buy	+115,000	New	+$23.4M	1.88%	14

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Rhenman & Partners Asset Management's TDOC Position: Q1 2023 in Review

Rhenman & Partners Asset Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 130,000 shares — an estimated $3.07M sold.

Rhenman & Partners Asset Management first reported a position in TDOC in Q4 2020 and held it in 9 quarters. The position peaked at $34.9M in Q2 2021. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

Rhenman & Partners Asset Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
Rhenman & Partners Asset Management sold 130,000 Teladoc Health shares in Q1 2023, an estimated $3.07M.
Rhenman & Partners Asset Management first reported a position in Teladoc Health in Q4 2020 and held it in 9 quarters.
Rhenman & Partners Asset Management's Teladoc Health position peaked at $34.9M in Q2 2021.
429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2023, filed 12 May 2023.